Ultra Clear Treatment
NDC Package 73122-126-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Ultra Clear Treatment is stop use and ask a doctor:If skin irritation becomes severe. Marketed by Ultraceuticals Us Llc, this product is identified by NDC 73122-126 and is authorized under FDA application part333D.

Identification & Billing

NDC Package Code
73122-126-01
Package Description
50 mL in 1 BOTTLE
Product Code
73122-126
11-Digit Billing Format
73122012601
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Ultra Clear Treatment
Dosage Form
-
Usage Information
Stop use and ask a doctor:If skin irritation becomes severe

Regulatory & Marketing

Labeler Name
Ultraceuticals Us Llc
FDA Application #
part333D
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
09-26-2019
Listing Expiration
12-31-2020
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73122-126-01 identifies a specific commercial package of 50 ml in 1 bottle of Ultra Clear Treatment, labeled by Ultraceuticals Us Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Ultraceuticals Us Llc on September 26, 2019. The current certification is valid through December 31, 2020.

How is this Ultraceuticals Us Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73122012601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73122-126-01
11-Digit CMS (5-4-2)
73122-0126-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.